Skip to main content
Year archive

Protalix BioTherapeutics, Inc. — 2023 filings

All 41 regulatory filings released by Protalix BioTherapeutics, Inc. (PLX) in 2023, sourced directly from the official regulator.

41 Filings
2023 Period
2023 filings (41)
Filing Released Lang
8-K
Regulatory Filings
2023-12-26 English
Interim / Quarterly Report Q3 2023
2023-11-06 English
8-K
Regulatory Filings
2023-11-06 English
Director's Dealing
2023-10-20 English
Director's Dealing
2023-10-03 English
Director's Dealing
2023-10-03 English
Director's Dealing
2023-10-03 English
Director's Dealing
2023-10-03 English
Director's Dealing
2023-10-03 English
Director's Dealing
2023-09-15 English
Director's Dealing
2023-09-15 English
8-K
Regulatory Filings
2023-09-12 English
Director's Dealing
2023-08-17 English
Director's Dealing
2023-08-17 English
Director's Dealing
2023-08-17 English
Director's Dealing
2023-08-17 English
Regulatory Filings
2023-08-11 English
Interim / Quarterly Report Q2 2023
2023-08-07 English
8-K
Regulatory Filings
2023-08-07 English
8-K
Regulatory Filings
2023-07-13 English
Regulatory Filings
2023-07-07 English
8-K
Regulatory Filings
2023-06-29 English
Regulatory Filings
2023-06-28 English
8-K
Regulatory Filings
2023-05-30 English
ARS
Annual Report
2023-05-19 English
Proxy Solicitation & Information Statement
2023-05-18 English
8-K
Regulatory Filings
2023-05-18 English
8-K
Regulatory Filings
2023-05-10 English
8-K
Regulatory Filings
2023-05-05 English
Interim / Quarterly Report Q1 2023
2023-05-04 English
8-K
Regulatory Filings
2023-05-04 English
Regulatory Filings
2023-05-02 English
Annual Report FY 2022
2023-05-01 English
Regulatory Filings
2023-02-27 English
8-K
Regulatory Filings
2023-02-27 English
Annual Report FY 2022
2023-02-27 English
8-K
Regulatory Filings
2023-02-27 English
8-K
Regulatory Filings
2023-02-24 English
Director's Dealing
2023-01-05 English
8-K
Regulatory Filings
2023-01-03 English
Major Shareholding Notification
2023-01-03 English